Evolus, Inc. (EOLS) Balance Sheet
As of 2026-06-30 (10-Q), Evolus, Inc. (EOLS) reported total assets of $248.0M, total liabilities of $278.9M and shareholders' equity of -$30.9M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $45.2M. Long-term debt: $156.7M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
EOLSEvolus, Inc.Follow EOLS — free
—
Price chart with a free account
- Market cap
- 463.0M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 93.2 | 109.9 | 102.6 | 146.3 | 53.9 | 62.8 | 87.0 | 53.8 | 45.2 | |
| Short-term investments | 0.0 | 19.9 | 5.0 | 0.0 | — | — | — | — | — | |
| Receivables | 0.0 | 10.7 | 9.7 | 14.7 | 22.4 | 30.5 | 47.7 | 54.7 | 62.4 | |
| Inventory | 0.0 | 6.4 | 3.4 | 1.8 | 18.9 | 11.0 | 12.2 | 27.0 | 40.9 | |
| Current assets | 94.3 | 152.2 | 127.6 | 178.8 | 100.8 | 112.4 | 151.3 | 142.9 | 167.5 | |
| Total assets | 171.8 | 240.4 | 209.1 | 257.5 | 178.0 | 189.0 | 232.6 | 225.9 | 248.0 | |
| Current liabilities | 5.3 | 24.4 | 180.2 | 57.7 | 46.5 | 48.3 | 63.0 | 75.3 | 98.7 | |
| Long-term debt | 0.0 | 73.5 | — | 71.2 | 71.9 | 120.4 | 121.5 | 146.1 | 156.7 | |
| Total liabilities | 87.5 | 161.0 | 282.0 | 175.6 | 159.5 | 209.7 | 227.0 | 249.0 | 278.9 | |
| Shareholders' equity | 84.4 | 79.5 | -73.0 | 81.9 | 18.5 | -20.7 | 5.5 | -23.1 | -30.9 |
USD millions · SEC XBRL
Evolus, Inc. — questions
- How much cash does Evolus, Inc. have?
- $45.2M in cash and cash equivalents as of 2026-06-30.
- How much debt does Evolus, Inc. have?
- $156.7M of long-term debt as of 2026-06-30.
- What are Evolus, Inc.'s total assets?
- $248.0M as of 2026-06-30.
- What is Evolus, Inc.'s shareholders' equity?
- -$30.9M as of 2026-06-30.
Every figure on this page comes from Evolus, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.